RxDoctor Payments Data

Robert Abdu, DO

Vascular Surgery · Manchester, NHNPI 1437670445

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,401 of the $2,032 with a category attached, or 68.9%. 14 manufacturers reported payments, led by Medtronic at 24.9% of the total. Reporting peaked in 2023 at $939 and has fallen 74.5% since, to $240 in 2025. That places this record below the midpoint for vascular surgery clinicians in NH, where the typical reported total is $2,156.

$2,032in general payments, 2019–2025

Across 29 payments — averaging $70.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$505
  • W. L. Gore & Associates, Inc.$499
  • Boston Scientific$301
  • Philips North America LLC$135
  • Tactile Systems Technology Inc$112
  • Intuitive Surgical$99
  • plus $381 from 8 others

What the payments were for

  • Grants$673%
  • Food & beverage$1,40169%
  • Education$56428%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,032 in reported general payments places this provider in the 40th percentile of 43 vascular surgery providers in New Hampshire.

See all vascular surgery providers in New Hampshire

Medicare billing

Part B allowed, 2024
$8,777
Medicare patients
62
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$7,148
ClopidogrelClopidogrel Bisulfate20$142
Oxycodone Hcl14$32

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Manchester

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →